Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

Lancet. 1974 Nov 16;2(7890):1157-60. doi: 10.1016/s0140-6736(74)90807-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Age Factors
  • Aged
  • Alprenolol / administration & dosage
  • Alprenolol / therapeutic use*
  • Clinical Trials as Topic
  • Coronary Care Units
  • Death, Sudden*
  • Female
  • Follow-Up Studies
  • Heart Function Tests
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Placebos
  • Recurrence
  • Sweden

Substances

  • Placebos
  • Alprenolol